PUBLISHER: The Business Research Company | PRODUCT CODE: 2036065
PUBLISHER: The Business Research Company | PRODUCT CODE: 2036065
Pre-sterilized nested vials are pharmaceutical containers supplied in a sterile, ready-to-use format, with individual vials arranged in nested configurations within trays or tubs. This design minimizes manual handling, reduces the risk of contamination, and supports automated aseptic filling, making them ideal for injectable and other sterile drug products.
The key product types of pre-sterilized nested vials include glass nested vials and plastic nested vials. Glass nested vials are pre-sterilized containers designed to hold multiple doses of injectable drugs or biologics in a nested arrangement for efficient handling and storage. Sterilization methods include gamma sterilization, ethylene oxide sterilization, steam sterilization, and others, with capacities such as 2R, 6R, 10R, 20R, and more. Applications include injectable drugs packaging, biologics packaging, vaccine packaging, clinical trial packaging, and aseptic fill-finish operations, serving hospitals, contract manufacturing organizations, research institutes, and other end users.
Tariffs have affected the pre-sterilized nested vials market by increasing the import costs of glass and plastic vials, sterilization equipment, and high-precision packaging machinery. This impact is most pronounced in North America and Europe, where manufacturers rely heavily on imported materials for sterile pharmaceutical packaging. The tariffs have also accelerated local production initiatives, promoted the development of alternative materials, and encouraged investment in cost-efficient automation solutions, creating opportunities for more resilient supply chains.
The pre-sterilized nested vials market research report is one of a series of new reports from The Business Research Company that provides pre-sterilized nested vials market statistics, including pre-sterilized nested vials industry global market size, regional shares, competitors with a pre-sterilized nested vials market share, detailed pre-sterilized nested vials market segments, market trends and opportunities, and any further data you may need to thrive in the pre-sterilized nested vials industry. This pre-sterilized nested vials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pre-sterilized nested vials market size has grown rapidly in recent years. It will grow from $1.24 billion in 2025 to $1.41 billion in 2026 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to rising demand for injectable drugs, adoption of pre-sterilized vials, growth of biologics and vaccines, increasing contract manufacturing operations, stringent pharmaceutical packaging regulations.
The pre-sterilized nested vials market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to automation in aseptic fill-finish, development of eco-friendly nested vials, expansion of vaccine manufacturing, adoption of advanced polymer and glass materials, integration with digital tracking and monitoring systems. Major trends in the forecast period include automated aseptic filling integration, pre-sterilized packaging adoption, nested vial handling automation, advanced material development, regulatory compliance optimization.
The growing adoption of biologics is expected to drive the expansion of the pre-sterilized nested vials market. Biologics adoption refers to the rising use of biologic therapies by healthcare providers and patients in routine clinical practice. This trend is driven by the capability of biologics to provide targeted therapeutic effects, especially in treating chronic, autoimmune, and metabolic diseases where conventional small-molecule therapies often demonstrate limited effectiveness. Pre-sterilized nested vials facilitate this adoption by providing ready-to-use, contamination-free primary packaging solutions that ensure product safety, maintain drug stability, and reduce preparation time during aseptic filling and administration. For instance, in October 2024, the Generics and Biosimilars Initiative (GaBI), a Belgium-based organization providing scientific information on generic and biosimilar medicines, reported that beyond the nine leading biologics, two additional complex biologic drugs-Novo Nordisk's Ozempic (semaglutide) and Eli Lilly's Trulicity (dulaglutide), both prescribed for type 2 diabetes-achieved significant sales in 2023, reaching approximately US$14 billion and US$7.2 billion, respectively. Therefore, the rising adoption of biologics is driving the growth of the pre-sterilized nested vials market.
Leading companies operating in the pre-sterilized nested vials market are focusing on developing innovative solutions such as container closure integrity to ensure sterile drug delivery, prevent contamination, and maintain the stability and safety of pharmaceutical products. Container closure integrity refers to a packaging system's ability to maintain a complete seal that prevents contamination, leakage, or loss of sterility. For example, in May 2024, West Pharmaceutical Services Inc., a US-based manufacturing company, launched Daikyo Crystal Zenith (CZ) Nested Vials in a Tub as ready-to-use, pre-sterilized cyclic olefin polymer (COP) vials for sensitive therapies like cell/gene treatments and radiopharmaceuticals. Available in 2 mL (100 vials/tub) and 10 mL (48 vials/tub) sizes with ISO 8362-1 glass-like exterior dimensions, they ensure cryogenic container closure integrity, low particulates (<2% USP <788>), high viral vector recovery, breakage resistance, and minimal chemical interactions.
In August 2025, SGD Pharma, a France-based manufacturing company, acquired Alphial S.r.l. for an undisclosed amount. This acquisition allows SGD Pharma to accelerate growth in the pharmaceutical packaging sector, improve operational efficiency, and provide a broader range of specialized glass solutions to meet evolving industry needs. Alphial S.r.l. is an Italy-based manufacturing company offering pre-sterilized, ready-to-use (RTU) vials.
Major companies operating in the pre-sterilized nested vials market are Corning Incorporated, Terumo Corporation, Nipro PharmaPackaging, West Pharmaceutical Services Inc., Gerresheimer AG, Datwyler Holding Inc., Stevanato Group, SCHOTT AG, Shandong Pharmaceutical Glass Co. Ltd., SGD Pharma, Bormioli Pharma, Adelphi Healthcare Packaging, DWK Life Sciences, Linuo Glassworks Group, SiO2 Materials Science, Jinan Youlyy Industrial Co. Ltd., Origin Pharma Packaging, Pacific Vial Manufacturing Inc., Daikyo Seiko Ltd., Qorpak, AptarGroup Inc., QCVIALZ LLC.
North America was the largest region in the pre-sterilized nested vials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pre-sterilized nested vials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pre-sterilized nested vials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pre-sterilized nested vials market consists of sales of pre-sterilized vials in cup-nest format, pre-sterilized nested vials with integrated closures, and pre-sterilized nested vial kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pre-Sterilized Nested Vials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pre-sterilized nested vials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pre-sterilized nested vials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pre-sterilized nested vials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.